Raphael Campeas
Overview
Explore the profile of Raphael Campeas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gillan C, Kalanthroff E, Evans M, Weingarden H, Jacoby R, Gershkovich M, et al.
JAMA Psychiatry
. 2019 Oct;
77(1):77-85.
PMID: 31596434
Importance: Dimensional definitions of transdiagnostic mental health problems have been suggested as an alternative to categorical diagnoses, having the advantage of capturing heterogeneity within diagnostic categories and similarity across them...
2.
Task-based fMRI predicts response and remission to exposure therapy in obsessive-compulsive disorder
Pagliaccio D, Middleton R, Hezel D, Steinman S, Snorrason I, Gershkovich M, et al.
Proc Natl Acad Sci U S A
. 2019 Sep;
116(41):20346-20353.
PMID: 31548396
Exposure and ritual prevention (EX/RP) is an effective first-line treatment for obsessive-compulsive disorder (OCD), but only some patients achieve minimal symptoms following EX/RP. Herein, we investigate whether task-based neural activity...
3.
Kalanthroff E, Steinman S, Schmidt A, Campeas R, Simpson H
Psychother Psychosom
. 2018 Jan;
87(1):52-54.
PMID: 29306946
No abstract available.
4.
Schneier F, Moskow D, Choo T, Galfalvy H, Campeas R, Sanchez-Lacay A
Depress Anxiety
. 2017 Oct;
34(12):1085-1095.
PMID: 29071764
Background: Separation anxiety disorder was recently recognized by fifth edition of the Diagnostic and Statistical Manual of Mental Disorders as a diagnosis in adults, but no publications to date have...
5.
Schneier F, Campeas R, Carcamo J, Glass A, Lewis-Fernandez R, Neria Y, et al.
Depress Anxiety
. 2015 Jun;
32(8):570-9.
PMID: 26115513
Background: Combined treatment with a selective serotonin reuptake inhibitor (SSRI) plus mirtazapine has shown superior efficacy in some studies of depression, but has not been studied in posttraumatic stress disorder...
6.
Foa E, Simpson H, Rosenfield D, Liebowitz M, Cahill S, Huppert J, et al.
J Clin Psychiatry
. 2014 Nov;
76(4):440-6.
PMID: 25375780
Objective: To compare outcomes after 6-month maintenance treatment of adults diagnosed with obsessive-compulsive disorder (OCD) based on DSM-IV criteria who responded to acute treatment with serotonin reuptake inhibitors (SRIs) augmented...
7.
Simpson H, Foa E, Liebowitz M, Huppert J, Cahill S, Maher M, et al.
JAMA Psychiatry
. 2013 Sep;
70(11):1190-9.
PMID: 24026523
Importance: Obsessive-compulsive disorder (OCD) is one of the world's most disabling illnesses according to the World Health Organization. Serotonin reuptake inhibitors (SRIs) are the only medications approved by the Food...
8.
Foa E, Simpson H, Liebowitz M, Powers M, Rosenfield D, Cahill S, et al.
J Clin Psychiatry
. 2013 Jun;
74(5):464-9.
PMID: 23759449
Objective: This article describes the long-term effects of augmenting serotonin reuptake inhibitors (SRIs) with exposure and ritual prevention or stress management training in patients with DSM-IV obsessive-compulsive disorder (OCD). Method:...
9.
Blanco C, Heimberg R, Schneier F, Fresco D, Chen H, Turk C, et al.
Arch Gen Psychiatry
. 2010 Mar;
67(3):286-95.
PMID: 20194829
Context: Medication and cognitive behavioral treatment are the best-established treatments for social anxiety disorder, yet many individuals remain symptomatic after treatment. Objective: To determine whether combined medication and cognitive behavioral...
10.
Simpson H, Foa E, Liebowitz M, Ledley D, Huppert J, Cahill S, et al.
Am J Psychiatry
. 2008 Mar;
165(5):621-30.
PMID: 18316422
Objective: Although serotonin reuptake inhibitors (SRIs) are approved for the treatment of obsessive-compulsive disorder (OCD), most OCD patients who have received an adequate SRI trial continue to have clinically significant...